News

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for WELIREG ...
KIRKLAND, QC, March 5, 2024 /CNW/ - As part of our commitment to embedding diversity, equity, and inclusion into our business, Merck Canada is continually exploring ways to give back to the ...
Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs and vaccines.
(RTTNews) - Merck Canada Inc., an affiliate of Merck & Co. Inc. (MRK), known as MSD outside the United States and Canada, announced that Health Canada has approved BRENZYS, a TNF-inhibitor, for ...
(RTTNews) - Drug major Merck & Co., Inc. (MRK) and Eisai announced Wednesday that KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) is available in Canada for the first-line treatment of adult ...
Merck Canada Logo (CNW Group/Merck Canada) In Canada, where the rates of many cancer types are projected to continue to decrease, melanoma remains a notable outlier. In fact, the number of Canadians ...
Merck & Co., Inc.’s MRK and partner Eisai announced that the FDA has issued a complete response letter (CRL) to their applications seeking approval of a combination of its blockbuster PD-L1 ...
Darmstadt, Germany, October 14, 2015 – Merck, a leading science and technology company, today announced the relaunch of its brand identity. The fundamental revision of the visual appearance as ...
Merck & Co said on Friday it would supply Canada with up to 1 million courses of molnupiravir, its experimental oral antiviral medicine for the treatment of COVID-19.
Merck & Co. operates under the Merck Sharp & Dohme brand (MSD) outside the U.S. and Canada. To tie the North American business into the global brand--despite the differing names--the entire group ...
(RTTNews) - Merck Canada Inc., an affiliate of Merck & Co. Inc. (MRK), known as MSD outside the United States and Canada, announced that Health Canada has approved BRENZYS, a TNF-inhibitor, for ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for WELIREG® ...